Skip to main content
. 2018 Sep 3;14:1563–1571. doi: 10.2147/TCRM.S169964

Figure 1.

Figure 1

Flow chart of the process of identifying and selecting study patients: type 2 diabetes patients initiated oral antidiabetic therapy from 2011 up until 2015.

Abbreviations: AD, antidiabetic drug; SU, sulfonylurea; DPP-4, dipeptidyl peptidase-4; AG, α-glucosidase; TZD, thiazolidinedione.